Samsung's drug-manufacturing unit plans to raise as much as $2.0 billion in November with what looks set to be South Korea's third-largest initial public offering (IPO).
Researchers from the University of Copenhagen have discovered a way of improving biotech drugs. Better, cheaper and more effective drugs to combat cancer, arthritis and many other disorders.
South Korea's Samsung Electronics said Tuesday it had bought US medical imaging firm NeuroLogica, as it seeks to explore new growth sources by expanding into the health sector.
(Phys.org)—Sean Hemp of Raleigh, N.C., a Ph.D. student in chemistry in the College of Science, is helping to invent new therapies that target genetic disease and cancer.